- Home
- MCW vs IMVT Comparison
MCW vs IMVT Comparison
Compare MCW & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCW
- IMVT
- Stock Information
- Founded
- MCW 1996
- IMVT N/A
- Country
- MCW United States
- IMVT United States
- Employees
- MCW N/A
- IMVT N/A
- Industry
- MCW
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MCW
- IMVT Health Care
- Exchange
- MCW Nasdaq
- IMVT Nasdaq
- Market Cap
- MCW 2.4B
- IMVT 2.5B
- IPO Year
- MCW 2021
- IMVT N/A
- Fundamental
- Price
- MCW $6.57
- IMVT $15.24
- Analyst Decision
- MCW Hold
- IMVT Buy
- Analyst Count
- MCW 6
- IMVT 10
- Target Price
- MCW $8.46
- IMVT $40.14
- AVG Volume (30 Days)
- MCW 1.2M
- IMVT 1.2M
- Earning Date
- MCW 04-30-2025
- IMVT 05-29-2025
- Dividend Yield
- MCW N/A
- IMVT N/A
- EPS Growth
- MCW 4.42
- IMVT N/A
- EPS
- MCW 0.24
- IMVT N/A
- Revenue
- MCW $1,017,200,000.00
- IMVT N/A
- Revenue This Year
- MCW $7.47
- IMVT $108.88
- Revenue Next Year
- MCW $7.76
- IMVT N/A
- P/E Ratio
- MCW $29.48
- IMVT N/A
- Revenue Growth
- MCW 8.18
- IMVT N/A
- 52 Week Low
- MCW $5.84
- IMVT $12.72
- 52 Week High
- MCW $8.60
- IMVT $34.47
- Technical
- Relative Strength Index (RSI)
- MCW 35.58
- IMVT 50.82
- Support Level
- MCW $7.09
- IMVT $13.79
- Resistance Level
- MCW $7.26
- IMVT $15.22
- Average True Range (ATR)
- MCW 0.18
- IMVT 0.69
- MACD
- MCW -0.06
- IMVT 0.14
- Stochastic Oscillator
- MCW 0.00
- IMVT 75.00
About MCW Mister Car Wash Inc.
Mister Car Wash Inc is a car wash brand offering express exterior and interior cleaning services. Express Exterior Locations offers express exterior cleaning services and Interior Cleaning Locations offers both express exterior and interior cleaning services. The company recognizes revenue from activities related to providing car wash services at its car wash locations that are geographically diversified throughout the United States and have similar economic characteristics and nature of services.
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).